These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 9732212
1. Strontium-89 chloride in the treatment of bone metastases from breast cancer. Baziotis N, Yakoumakis E, Zissimopoulos A, Geronicola-Trapali X, Malamitsi J, Proukakis C. Oncology; 1998; 55(5):377-81. PubMed ID: 9732212 [Abstract] [Full Text] [Related]
2. Strontium 89 therapy for the palliation of pain due to osseous metastases. Robinson RG, Preston DF, Schiefelbein M, Baxter KG. JAMA; 1995 Aug 02; 274(5):420-4. PubMed ID: 7542352 [Abstract] [Full Text] [Related]
3. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Dafermou A, Colamussi P, Giganti M, Cittanti C, Bestagno M, Piffanelli A. Eur J Nucl Med; 2001 Jul 02; 28(7):788-98. PubMed ID: 11504074 [Abstract] [Full Text] [Related]
4. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer. Pons F, Herranz R, Garcia A, Vidal-Sicart S, Conill C, Grau JJ, Alcover J, Fuster D, Setoain J. Eur J Nucl Med; 1997 Oct 02; 24(10):1210-4. PubMed ID: 9323260 [Abstract] [Full Text] [Related]
5. Systemic radionuclide therapy in pain palliation. Liepe K, Runge R, Kotzerke J. Am J Hosp Palliat Care; 2005 Oct 02; 22(6):457-64. PubMed ID: 16323716 [Abstract] [Full Text] [Related]
6. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience. Lee CK, Aeppli DM, Unger J, Boudreau RJ, Levitt SH. Am J Clin Oncol; 1996 Apr 02; 19(2):102-7. PubMed ID: 8610630 [Abstract] [Full Text] [Related]
10. Strontium-89 therapy and imaging with bremsstrahlung in bone metastases. Uchiyama M, Narita H, Makino M, Sekine H, Mori Y, Fukumitsu N, Kawakami K. Clin Nucl Med; 1997 Sep 02; 22(9):605-9. PubMed ID: 9298293 [Abstract] [Full Text] [Related]
11. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group. Piffanelli A, Dafermou A, Giganti M, Colamussi P, Pizzocaro C, Bestagno M, Italian Association of Nuclear Medicine (AINM). Q J Nucl Med; 2001 Mar 02; 45(1):100-7. PubMed ID: 11456368 [Abstract] [Full Text] [Related]
13. The correlation between palliation of bone pain by intravenous strontium-89 and external beam radiation to linked field in patients with osteoblastic bone metastases. Ron IG, Stav O, Vishne T, Evan-Sapir E, Soyfer V, Agai R, Cherny N, Kovner F. Am J Clin Oncol; 2004 Oct 02; 27(5):500-4. PubMed ID: 15596920 [Abstract] [Full Text] [Related]
16. Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain. Berna L, Carrio I, Alonso C, Ferré J, Estorch M, Torres G. Eur J Nucl Med; 1995 Oct 02; 22(10):1101-4. PubMed ID: 8542891 [Abstract] [Full Text] [Related]
19. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases]. Liepe K, Franke WG, Kropp J, Koch R, Runge R, Hliscs R. Nuklearmedizin; 2000 Sep 02; 39(6):146-51. PubMed ID: 11057405 [Abstract] [Full Text] [Related]
20. Strontium chloride Sr 89 for treating pain from metastatic bone disease. Nightengale B, Brune M, Blizzard SP, Ashley-Johnson M, Slan S. Am J Health Syst Pharm; 1995 Oct 15; 52(20):2189-95. PubMed ID: 8564588 [Abstract] [Full Text] [Related] Page: [Next] [New Search]